BioFirst Overview
- Founded
- 2008
- Status
- Acquired/Merged
- Employees
- 360
- Latest Deal Type
- M&A
- Latest Deal Amount
- $14.2M
BioFirst General Information
Description
Developer of plant proteases products intended to substitute chemicals products. The company produces and markets natural technologies and products in agriculture, para pharmaceuticals, agri-foodstuffs, cosmetics, and health care and are environmentally friendly and sustainable alternatives to existing chemical products, enabling customers to get products that are safe for them as well as the environment.
Contact Information
Primary Industry
Other Chemicals and Gases
Other Industries
Other Commercial Products
Industrial Chemicals
Acquirer
Primary Office
- Drève Richelle 161 B4
- 1410 Waterloo
- Belgium
BioFirst Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 22-Nov-2011 | $14.2M | 000.00 | Completed | Generating Revenue | |
| 1. Early Stage VC | Completed | Startup |
BioFirst Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialBioFirst Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Compagnie du Bois Sauvage | Corporation | Minority | 000 0000 | 000000 0 | |
| Florinvest | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |